Signal Explorer

Classified Board Director Election

Segment Aggregation Disclosure Patent Family Portfolio Disclosure Cash Flow Statement Investing Activities Rsu Psu Vesting Schedule Disclosed Financing Activities Cash Flow Disclosure Net Loss Reported Cybersecurity Risk Management Program Disclosure Cybersecurity Breach Reputational Harm Disclosure Deferred Tax Asset Valuation Disclosure Protocol Amended Institutional Investment Codm Segment Reporting Disclosure Non Solicitation Covenant Closing Deliverables Specified

Regulatory Designation Only

Clinical Trial Result Combination Therapy Mentioned Secondary Endpoint Mentioned Lead Asset Progress Clinical Hold

Interim Data Positive Fda Aligned Patient Retention High Gene Therapy Aav Safety Differentiated Publication Positive Expanded Access Program Active

Ipo Net Proceeds Disclosure Corporate Organization And Standing Representation Registration Rights Piggyback Provision Ipo Or Capital Raising Completion Institutional Investment Use Of Proceeds Disclosure

Segment Aggregation Disclosure Rsu Psu Vesting Schedule Disclosed Financing Activities Cash Flow Disclosure Cash Flow Statement Investing Activities Net Loss Reported Fair Value Hierarchy Reconciliation Disclosed Fast Track Designation Received Fast Track Granted Orphan Status Granted Other Income Expense Disclosure Enrollment Ahead Of Schedule

Regulatory Designation Only Clinical Trial Result Indication Expansion

Orphan Drug Designation

Clinical Trial Result Combination Therapy Mentioned Lead Asset Progress

Interim Data Positive Board Committee Member Listing Gene Therapy Aav Kol Endorsement Patient Retention High Form 8K Filing Disclosure Fda Aligned Safety Differentiated Fast Track Granted Fast Track Designation Received

Ind Submission Planned

Trial Endpoint Missed